[Evidence summary:] What is the latest national and international evidence about the existence of long COVID or post-COVID and its persistence for COVID-19 survivors? [v2.0]
| dc.contributor.author | National Health Library & Knowledge Service (NHLKS) | |
| dc.contributor.author | Leen, Brendan | |
| dc.contributor.author | McCarthy, Siobhan | |
| dc.contributor.author | Quinn, Emma | |
| dc.contributor.author | Helen, Clark | |
| dc.date.accessioned | 2022-05-09T13:39:09Z | |
| dc.date.available | 2021-02-01T12:57:47Z | |
| dc.date.available | 2022-05-09T13:39:09Z | |
| dc.date.issued | 2022-04-28 | |
| dc.identifier.uri | http://hdl.handle.net/10147/628919 | |
| dc.description | Main Points 1. Two distinct clinical scenarios are emerging: 1. patients with initially severe illness requiring hospitalization whose rehabilitation and recovery can be complex and slow; and 2. ongoing debilitating symptoms in patients who may not have required hospital admission initially. It is the latter who are sometimes referred to as ‘long COVID’ patients. ‘Long COVID’ is a term first coined on social media. 2. There is an absence of higher-quality evidence as yet about the longer-term effects of COVID-19, but a growing body of anecdotal/observational evidence and some preliminary studies suggest persistence of at least one and sometimes several symptoms. 3. Fatigue, dyspnea, breathlessness and cough, joint and muscle pain, chest pain and palpitations are among the most commonly reported symptoms. 4. It is speculated that the virus may injure multiple organs and/or bodily systems. Potential long-term effects include damage to lungs, the immune system, the heart, and the brain, resulting in neurological complications, olfactory dysfunction and/or chronic fatigue similar to CFS/ME. 5. There is potential for a significant and persistent negative mental health impact, based on previous experience with other pandemics. 6. Many patients recover spontaneously (if slowly) with holistic support, rest, symptomatic treatment, and a gradual increase in activity. Indications for specialist assessment include clinical concern along with respiratory, cardiac or neurological symptoms that are new, persistent, or progressive. 7. There are several ongoing studies investigating the aetiology, outcomes and management of persisting symptoms that will in time provide higher quality evidence. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Health Service Executive | en_US |
| dc.relation.ispartofseries | Question 159 | en_US |
| dc.subject | CORONAVIRUS | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | REHABILITATION | en_US |
| dc.subject | POST VIRAL SYNDROME | en_US |
| dc.subject | RECOVERY | en_US |
| dc.title | [Evidence summary:] What is the latest national and international evidence about the existence of long COVID or post-COVID and its persistence for COVID-19 survivors? [v2.0] | en_US |
| dc.type | Other | en_US |
| refterms.dateFOA | 2021-02-01T12:57:56Z |
Files in this item
This item appears in the following Collection(s)
-
HSE Library Summaries of Evidence
Evidence summaries and reviews on the management and treatment of Novel Coronavirus Covid-19 and other clinical topics